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Abstract
Background: The latest scientific reports raise concerns about the rapidly increasing burden of chronic diseases in
the state of Qatar. Pregnant Qatari women often confront complications during pregnancy including gestational
diabetes, hypertension, abortion and stillbirth. The investigation of early life environmental, genetic, nutritional and
social factors that may affect lifelong health is of great importance. Birth cohort studies offer a great opportunity to
address early life hazards and their possible long lasting effects on health.
Methods/design: The Qatari Birth Cohort study is the first mother-child cohort study in the Middle East Area that
aims to assess the synergetic role of environmental exposure and genetic factors in the development of chronic
disease and monitor woman and child health and/or obstetric characteristics with high prevalence. The present
manuscript describes the recruitment phase of the study (duration: 2 years; expected number: 3000 families), where
the pregnant Qatari women and their husbands are being contacted before the 15th week of gestation at the
Primary Health Care Centers. The consented participants are interviewed to obtain information on several factors
(sociodemographic characteristics, dietary habits, occupational/environmental exposure) and maternal
characteristics are assessed based on anthropometric measurements, spirometry, and blood pressure. Pregnant
women are invited to provide biological samples (blood and urine) in each trimester of their pregnancy, as well as
cord blood at delivery. Fathers are also asked to provide biological samples.
Discussion: The present study provides invaluable insights into a wide range of early life factors affecting human
health. With a geographical focus on the Middle East, it will be a resource for information to the wider scientific
community and will allow the formulation of effective policies with a primary focus on public health interventions
for maternal and child health.
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Background
Early life events during critical developmental periods,
may have significant impacts on the maintenance of lifelong
healthiness. Recent epidemiological and experimental evi-
dence points out how an adverse intrauterine environment,
related to maternal dietary or placental insufficiency, could
program susceptibility of the fetus to later development of
cardiovascular or metabolic diseases such as obesity, hyper-
tension, insulin resistance and type 2 diabetes [1, 2]. The
‘early life programming’ concept was originally proposed so
as to explain the link between maternal nutritional deficits
during pregnancy, low birth weight (less than 2.500 g) and
risk for disease in lifespan [3]. This concept has been later
expanded to the developmental origins of health and
disease (DOHaD) model, which links fetal development
to an unfavorable environment with the development of
non-communicable diseases in later life [4, 5]. Psychiatric
research has been inspired by the DOHaD model with a
key focus being to provide insights into the etiology of
mental disorders emerging from early life traits. Pregnancy
and birth cohort studies provide the most suitable design
to assess early life hazards at critical time points during
development, and their possible long-lasting effects.
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The rising incidence of chronic disease constitutes a major
public health issue affecting many countries worldwide. In
the Middle East, recent reports have raised this concern
for member states of the Gulf Cooperative Council (GCC),
where a higher burden of chronic diseases than most
developed countries is observed [6–8]. The World Health
Organization (WHO) Qatar STEPS survey of chronic
disease risk factors in 2012 reported that almost half of the
general Qatari population is at high risk for developing
chronic diseases [9]. High prevalence rates of diabetes
[10], cardiovascular disease [11], metabolic syndrome
[12], hypertension [13], and mental illness have been re-
ported in the population of Qatar [14]. Given the high
levels of obesity and diabetes in Qatar, it is likely that a
significant percentage of pregnancy complications will be
associated with maternal obesity, type 2 diabetes and gesta-
tional diabetes. There is also a high concern on the in-
creased incidence of mental disorders (such as postpartum
depression, anxiety, and personality disorder) in Qatari
women at the reproductive age [15].
In line with the increased incidence of chronic diseases
in Qatar, there also exists a higher than expected preva-
lence of specific adverse birth outcomes such as stillbirths
(6.9%), preterm births (8.5%) and low birth weight (8.8%)
deliveries [16, 17]. Recent studies have reported that the
impact of stillbirths on Qatar’s perinatal mortality has in-
creased 17% within two decades [16], but with no suffi-
cient data explaining this incidence. Moreover, gestational
diabetes and gestational hypertension are the main com-
plications observed in Qatari pregnant women [18].
Given the limited number of birth cohort studies in
the Middle East, which mainly focus on specific health
outcomes, the establishment of a mother-child cohort in
Qatar is an excellent opportunity to address a broad
range of research questions. The Qatari Birth Cohort Study
(QBiC) aims to examine how environmental, genetic, nutri-
tional and social factors affect health at first stages of life
and childhood. The study focuses on the two most critical
time windows of human development, the in utero
exposure of the fetus through maternal exposures and the
early life exposures as they are related to transgenerational
alterations in ‘omic’ profile and disease onset. This project
will comprise risk and benefit analyses including maternal
and early life health monitoring as well as an extensive
range of ‘omic’ analyses for the in depth investigation of the
impact of genome-exposure synergy in the establishment of
adverse birth outcomes and chronic diseases development.
Moreover, the present study will investigate the increasing
stillbirth rates [16, 17] and the concern of high abortion
that was raised by the Permanent Population Committee at
Qatar Population Status 2012 report [19]. The envisaged
work has major potential for translational exploitation both
national and international aiming to develop harmonized
data for future collaborations with international birth
cohorts. The purpose of the present protocol is to intro-
duce the study design and the methods that are used for
the recruitment phase of this longitudinal birth cohort in
the state of Qatar.
Methods/design
The QBiC study is the first mother-child cohort in the
state of Qatar that aims to recruit and follow up for 5 years
a sample of 3000 pregnant women and their children from
birth to childhood. The main objectives of the cohort are
briefly cited below:
 To evaluate maternal health pre- and postnatally
including gestational diabetes, metabolic syndrome,
obesity and postpartum depression
 To identify gene-environmental interaction affecting
fetal growth and child health
 To assess the prevalence of nutritional, environmental,
biological, and psychosocial exposures in the prenatal
period and early childhood
 To examine the impact of these exposures on
health-related outcomes such as birth outcomes,
neurodevelopment, obesity, asthma and allergies that
appear in early life and is likely to perpetuate into
late childhood or adulthood
 To apply new innovative technology platforms
"omics" to transfer knowledge from bench side to
population side
 To provide valuable evidence-based data to policy
makers so as to design effective policies that improve
health
This is a multidisciplinary five year cohort study that is
developed by the Ministry of Public Health in Qatar
(MOPH-Q) in collaboration with various national re-
search institutions, such as Primary Health Care Centers,
Qatar University, Weill Cornell Medical Center-Q, Qatar
Biomedical Research Institute, Qatar BioBank, Qatar
Environmental and Energy Research Institute, Texas A &
M University-Q, Sidra Medical Center, Hamad Medical
Corporations, and international collaboration with the
Barcelona Institute for Global Health (ISGlobal) in Spain.
Ethical approval
The MOPH-Q has provided local Institutional Review
Boards (IRBs) with national guidelines for overseeing re-
search studies that involve vulnerable subjects such as
pregnant women and children in order to maintain the
safety and wellbeing of these participants. Large cohorts
that involve collection of biological samples and handle
genetic information present emerging ethical and legal
issues including, but not limited to, privacy, psychological,
legal, social, consent, etc. Many of these risks involve the
potential for a breach of confidential information.
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Therefore, decreasing the risks of a breach of confidential-
ity reduces the risk of subsequent psychological, privacy,
legal, and social harms. In order to mitigate those risks
while conducting this cohort study, three main approaches
are currently in place to secure collected information: 1-
physical procedures that include locked cabinets, locked
offices, and housing of database servers in rooms with
tightly controlled access. 2- Technical procedures that in-
clude password protection, encryption, and firewalls. These
procedures are designed to limit access to confidential
information to those individuals or computer programs that
have been granted access rights. 3- Administrative proce-
dures such as procedures for training research staff, confi-
dentiality agreements, and certificates of confidentiality. In
addition, continuous training sessions is provided to the
research team ensuring that every step in participation is
understood (e.g., translating documents to appropriate lan-
guages). Trained staff assesses the informed consent and
make sure that the participants have understood the pur-
pose of the study, including the duration of participation,
procedures/methods, risks and benefits, and the terms of
confidentiality. It is clearly stated within the consent form
and the information flyer that their participation is volun-
tary at every point in the project.
The study has been reviewed and ethically approved by
the Institutional Review Board (IRB) of the Qatar BioBank
Ethics Committee (Protocol ID: Full Board/2017/RES-
ACC-0067/0019).
Study population
Eligible participants for this study are all pregnant
women who have lived in Doha for at least 15 years, and
will give birth in Qatar within the 2 year period
(anticipated number: 3000 families) of recruitment along
with their husbands. This is the first phase of the study
where the pregnant Qatari women and their husbands
are being contacted before the 15th week of gestation at
the Primary Health Care Centers (PHCC) in Doha,
Qatar. Study participants need to be residents in the
study area, older than 16 years, with no communication
handicap. The consented participants are interviewed to
obtain information on several sociodemographic and
lifestyle factors and maternal characteristics are assessed
based on anthropometric measurements, spirometry, blood
pressure and other clinical measurements. Pregnant women
are invited to provide blood, urine, saliva, hair and feces
samples throughout their pregnancy, as well as cord blood
and tissue, placental tissue, colostrum and breast milk at
delivery, according to the scheduled visits (Fig. 1).
Recruitment and data collection
Research assistants contact pregnant women at the
PHCC during their first scheduled major ultrasound test,
and kindly invite them to participate in the QBiC study.
Those interested to participate are scheduled for a visit
at Qatar Biobank where they have the opportunity to
discuss the study in depth with a research member and
provide a written consent form. Consented participants,
are invited to complete a baseline questionnaire, via face
to face interview, including sociodemographic and lifestyle
characteristics, and environmental exposures. Table 1 pro-
vides an overview of assessments and data that are
collected at recruitment phase up to delivery for the preg-
nant women, the fathers and the fetus. Dietary habits of
the women are assessed with the use of a food frequency
questionnaire (FFQ) and 24-h recalls. Research assistants
Fig. 1 QBiC follow-up visits during pregnancy
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also assess anthropometric measurements of the partici-
pants including height, weight, waist circumference and
hip circumference, bio-impedance analysis, cognitive func-
tion test, grip strength, vision, cardiovascular system (i.e.
blood pressure, electrocardiogram, arterial stiffness, ca-
rotid ultrasound), respiratory function (by spirometry) and
fetus ultrasound measurements.
During the third trimester, pregnant women will be
approached again for a follow up visit similar to the first
one where maternal stress will be also assessed via ques-
tionnaire. Pregnancy-related complications and fetal
ultrasound measurements will be obtained by the med-
ical records of the participants. At birth, research assis-
tants will clinically examine the infant (weight, length,
anogenital distance, head circumference) and collect in-
formation on the type of delivery, infant sex and gesta-
tional age. Pregnant women will be invited to provide
blood and urine samples at the scheduled visits during
pregnancy, as well as cord blood and colostrum at deliv-
ery. Fathers who accompany their wife will also be in-
vited to participate in the study. Once they agree they
will be invited for a visit at Qatar Biobank where they
will be informed about the study by trained personnel.
Consented participants will be asked to complete a face
to face questionnaire regarding their lifestyle and med-
ical history and to provide biological samples (Blood,
urine, saliva, feces and semen). All clinical visits of the
participants will be located at Qatar Biobank.
The biochemical profile of the pregnant women, their
husbands and their children will be assessed including
total cholesterol, high-density lipoprotein (HDL), low-
density lipoprotein (LDL), glucose, insulin, thyroid hor-
mones and antibodies, leptin, adiponectin, C - reactive
protein (CRP), inflammatory biomarkers. ‘Omic’ analyses
will be conducted in mothers, fathers and children with
main focus on the identification of early markers of
Table 1 Data planned to be collected at recruitment phase up to delivery
Follow-up Questionnaires Clinical examination Ultrasound measurements Biological samples
Mother
12–15 weeks General
FFQ
24 h recall
Anthropometric characteristics
Skinfolds
Bioimpedance
SCORAD test
Metabolic syndrome
Blood pressure
Spirometry
Thyroid malfunction
Gestational diabetes
Placental function: resistance indices
of the uterine and umbilical arteries
Blood
Urine
Saliva
Feces
32 weeks General
FFQ
24 h recall
Anthropometric characteristics
Bioimpedance
Skinfolds
Blood pressure
Spirometry
Thyroid malfunction
Gestational diabetes
Placental function: resistance indices
of the uterine and umbilical arteries
Blood
Urine
Saliva
Feces
Delivery Psychological Gestational diabetes, preeclampsia,
hypertension
Father
1st Visit General Anthropometric characteristics
Bioimpedance
Skinfolds
Blood pressure
Blood
Urine
Saliva
Feces
Semen
Fetus
12–15 weeks CRL, HC, BPD, FL, AC
32 weeks HC, BPD, FL, AC
Organ development: brain, heart, kidneys,
blood flow
Birth Clinical records: induced abortion fetal
or perinatal loss, caesarean
Sex, weight, length, HC, AC, Apgar score Cord blood
Cord tissue
Placenta
Meconium
Colostrum
Breast milk
Hair
Abbreviations: FFQ Food Frequency Questionnaire, CRL Crown-rump length, HC head circumference, BPD biparietal diameter, FL femur length, AC Abdominal circumference
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maternal health effects and reproductive outcomes and
on the evaluation of gene-environment interactions.
Withdrawal
It is a fundamental right of the participant to withdraw
from the study at any time without explanation. Preg-
nant women and their husbands are informed of their
right to withdraw at any time and whether they wish
their samples collected up to that point to be destroyed
and their personal data erased from the databases. How-
ever, samples and data generated from their samples that
have already been provided to other researchers or re-
search centers or are placed in a formal research data-
base cannot be withdrawn.
Data warehouse and biological samples
The enormous amount of data expected to be generated
will be incorporated in order to provide an integrated
data warehouse at the Qatar biobank (QBB). A secure and
private password will be required in order to proceed with
the data exchange. Access to these protected data will be
limited to the project researchers. Each participant of the
study is allocated with a unique study number and this will
be used to identify its data throughout the study. Personal
details such as name, surname or date of birth will never
appear on the samples, and the generated data will be
untraceable in order to protect confidential individual infor-
mation. The QBB will be responsible for the biological sam-
ples collected at the different time points, for the biosample
processing and their provision to other collaborators [20].
At a later stage a common database will be created includ-
ing all available information such as nutritional, lifestyle, en-
vironmental exposures, sociodemographic characteristics,
biomarkers and clinical data. All samples will be stored in
ultra-low temperature freezers (−80 °C).
Statistical considerations
Additional challenges related to evidence-based epidemio-
logical studies include the investigation of multiple expo-
sures and outcomes. Most commonly, studies examine the
effect of a single exposure to a single outcome, whereas
pregnant women and children are exposed to multiple
hazards. In the current study, the burden of disease esti-
mates in relation to environmental, lifestyle, nutritional
exposures will be obtained by integrating exposure, bio-
marker and outcome data, along with the corresponding
risk estimates and exposure-response data. Initially, one ex-
posure-one health outcome assessments will be con-
ducted followed by more advanced models that will be
developed incorporating genetic susceptibility to capture
the observed complexity and try to integrate risk and bene-
fits in a more holistic model through analyses from sources
to health outcomes. Given the complexity of the dataset
that will be originated from this study, it is expected that an
interplay between a priori biological knowledge and ‘un-
supervised’ statistical methods will be the most fruitful
approach to discovery. For example, pathway analysis will
exploit both existing databases and already developed
statistical tools (such as Factor Analysis and Latent Class
Analysis) to identify patterns [21, 22]. Another challenge
for the present study will be to have complete datasets of
measurements for all mother-children pairs instead of
limited subsets of measurements for a subsample of the
total participants, related to specific hypotheses. In these
cases, the use of imputation techniques, where applicable,
will be effective in reducing the bias resulting from miss-
ing values [23]. This will provide researchers the flexibility
to investigate the effect of a wider range of exposures and
their interaction.
Discussion
As with all longitudinal cohort studies a major concern is
to select the study participants from the source population
and avoid as much as possible any selection bias arising
from the procedures followed at the recruitment phase
and/or during the procedure of retaining them in the study
[24]. In order to address these biases it will be necessary to
regularly examine the differences in characteristics between
participants and non-participants according to the research
questions. At recruitment, individuals who volunteer to
participate in a study have generally different baseline char-
acteristics than the non-responders. Sample attrition is
(withdrawals or loss to follow up) a very common source of
bias in cohort studies and it will be a big challenge for
QBiC study to keep the families enrolled for long term fol-
low ups. Regular contact with the families, personal invita-
tions, survey publicity and consecutive newsletters will be
needed in order to retain the study participants and over-
come attrition bias. Additional effort will also be required
by the researchers to maintain representativeness through-
out the study.
One of the main strengths of the QBiC study is that it
will be the first large scale mother-child cohort study in
the Middle East studying the gene-environment interac-
tions associated with health impact. It is a unique, national,
evidence-based, epidemiological study designed to assess
global viewing on how various types of environmental ex-
posures co-exist and jointly with individual genome vari-
ability impact on health during critical developmental
periods. This multi-disciplinary project will assess the syn-
ergetic role of environmental exposure and genetic factors
in the development of chronic disease and monitor woman
and child health and/or obstetric characteristics with high
prevalence in the state of Qatar. Novel tools and methods
will be implemented to obtain estimates of individual envir-
onmental exposures including outdoor and indoor air pol-
lution, for study participants.
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Proper recruitment strategy of the study will provide ex-
cellent opportunity to researchers to bring together several
key elements in terms of sample size, sampling strategy,
exposure measures and phenotyping characterization. This
way the research team will be able to more efficiently ad-
dress future challenges regarding the following phases of
the study. The rapid change in biotechnology indicates that
innovative approaches will have to be continuously applied
in QBiC study. The harmonization of data within the study
will allow to develop future project collaborations with
other European and International birth cohorts. The need
for a broader geographical representation of the exist-
ing or new birth cohorts constitutes QBiC important,
as the unique birth cohort study in Middle East. It will
provide information to the wider scientific community
and through joint governance and clear data access policies
aims to participate to interdisciplinary research and share
of the longitudinal data, and thus contribute to science and
public health agenda.
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